Cecilia Hillard - Publications

Pharmacology and Toxicology Medical College of Wisconsin, Milwaukee, WI, United States 

185 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Doncheck EM, Liddiard GT, Konrath CD, Liu X, Yu L, Urbanik LA, Herbst MR, DeBaker MC, Raddatz N, Van Newenhizen EC, Mathy J, Gilmartin MR, Liu QS, Hillard CJ, Mantsch JR. Sex, stress, and prefrontal cortex: influence of biological sex on stress-promoted cocaine seeking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32303052 DOI: 10.1038/s41386-020-0674-3  0.64
2020 Hanlon EC, Leproult R, Stuhr KL, Doncheck EM, Hillard CJ, Van Cauter E. Circadian misalignment of the 24-hr profile of endocannabinoid 2-arachidonoylglycerol (2-AG) in obese adults. The Journal of Clinical Endocrinology and Metabolism. PMID 31970413 DOI: 10.1210/clinem/dgaa028  0.68
2019 Yasmin F, Colangeli R, Morena M, Filipski S, van der Stelt M, Pittman QJ, Hillard CJ, Teskey GC, McEwen BS, Hill MN, Chattarji S. Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala. Proceedings of the National Academy of Sciences of the United States of America. PMID 31843894 DOI: 10.1073/pnas.1910322116  0.96
2018 Hill MN, Eiland L, Lee TTY, Hillard CJ, McEwen BS. Early life stress alters the developmental trajectory of corticolimbic endocannabinoid signaling in male rats. Neuropharmacology. PMID 30496752 DOI: 10.1016/j.neuropharm.2018.11.036  0.96
2018 Balsevich G, Sticht M, Bowles NP, Singh A, Lee TTY, Li Z, Chelikani PK, Lee FS, Borgland SL, Hillard CJ, McEwen BS, Hill MN. Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance. Proceedings of the National Academy of Sciences of the United States of America. PMID 29967158 DOI: 10.1073/pnas.1802251115  0.96
2018 Berger AL, Henricks AM, Lugo JM, Wright HR, Warrick CR, Sticht MA, Morena M, Bonilla I, Laredo SA, Craft RM, Parsons LH, Grandes PR, Hillard CJ, Hill MN, McLaughlin RJ. The Lateral Habenula Directs Coping Styles Under Conditions of Stress Via Recruitment of the Endocannabinoid System. Biological Psychiatry. PMID 29887035 DOI: 10.1016/j.biopsych.2018.04.018  0.96
2017 McReynolds JR, Doncheck EM, Li Y, Vranjkovic O, Graf EN, Ogasawara D, Cravatt BF, Baker DA, Liu QS, Hillard CJ, Mantsch JR. Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid Mobilization in the Prelimbic Cortex. Biological Psychiatry. PMID 29100630 DOI: 10.1016/j.biopsych.2017.09.024  0.64
2017 Doncheck EM, Urbanik LA, DeBaker MC, Barron LM, Liddiard GT, Tuscher JJ, Frick KM, Hillard CJ, Mantsch JR. 17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28825421 DOI: 10.1038/npp.2017.170  0.64
2017 Belle L, Zhou V, Stuhr KL, Beatka M, Siebers EM, Knight JM, Lawlor MW, Weaver C, Hashizume M, Hillard CJ, Drobyski WR. Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD. Jci Insight. 2. PMID 28724796 DOI: 10.1172/jci.insight.93726  0.68
2017 Dean C, Hillard CJ, Seagard JL, Hopp FA, Hogan QH. UPREGULATION OF FATTY ACID AMIDE HYDROLASE (FAAH) IN THE DORSAL PERIAQUEDUCTAL GRAY IS ASSOCIATED WITH NEUROPATHIC PAIN AND REDUCED HEART RATE IN RATS. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00481.2016. PMID 28148494 DOI: 10.1152/ajpregu.00481.2016  0.32
2016 Dean C, Hillard CJ, Seagard JL, Hopp FA, Hogan QH. COMPONENTS OF THE CANNABINOID SYSTEM IN THE DORSAL PERIAQUEDUCTAL GRAY ARE RELATED TO RESTING HEART RATE. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00154.2016. PMID 27280429 DOI: 10.1152/ajpregu.00154.2016  0.32
2016 Gray JM, Wilson CD, Lee TT, Pittman QJ, Deussing JM, Hillard CJ, McEwen BS, Schulkin J, Karatsoreos IN, Patel S, Hill MN. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. Psychoneuroendocrinology. 66: 151-158. PMID 26821211 DOI: 10.1016/j.psyneuen.2016.01.004  1
2015 Hillard CJ. The Endocannabinoid Signaling System in the CNS: A Primer. International Review of Neurobiology. 125: 1-47. PMID 26638763 DOI: 10.1016/bs.irn.2015.10.001  1
2015 Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E. Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol. Sleep. PMID 26612385 DOI: 10.5665/sleep.5546  1
2015 Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nature Reviews. Neuroscience. 16: 705-18. PMID 26585799 DOI: 10.1038/nrn4036  1
2015 McReynolds JR, Doncheck EM, Vranjkovic O, Ganzman GS, Baker DA, Hillard CJ, Mantsch JR. CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats. Psychopharmacology. PMID 26455361 DOI: 10.1007/s00213-015-4092-x  1
2015 Hillard CJ. Endocannabinoids and the Endocrine System in Health and Disease. Handbook of Experimental Pharmacology. 231: 317-39. PMID 26408166 DOI: 10.1007/978-3-319-20825-1_11  1
2015 Vázquez C, Tolón RM, Grande MT, Caraza M, Moreno M, Koester EC, Villaescusa B, Ruiz-Valdepeñas L, Fernández-Sánchez FJ, Cravatt BF, Hillard CJ, Romero J. Endocannabinoid regulation of amyloid-induced neuroinflammation. Neurobiology of Aging. PMID 26362942 DOI: 10.1016/j.neurobiolaging.2015.08.003  1
2015 Lee TT, Hill MN, Hillard CJ, Gorzalka BB. Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats. Neuropharmacology. 99: 89-97. PMID 26192544 DOI: 10.1016/j.neuropharm.2015.07.021  1
2015 Vázquez C, Tolón RM, Pazos MR, Moreno M, Koester EC, Cravatt BF, Hillard CJ, Romero J. Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies. Neurobiology of Disease. 79: 41-50. PMID 25917763 DOI: 10.1016/j.nbd.2015.04.005  1
2015 Bowles NP, Karatsoreos IN, Li X, Vemuri VK, Wood JA, Li Z, Tamashiro KL, Schwartz GJ, Makriyannis AM, Kunos G, Hillard CJ, McEwen BS, Hill MN. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America. 112: 285-90. PMID 25535367 DOI: 10.1073/pnas.1421420112  1
2015 Wang ZY, Wang P, Hillard CJ, Bjorling DE. Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase. Journal of Molecular Neuroscience : Mn. 55: 968-76. PMID 25374388 DOI: 10.1007/s12031-014-0453-x  1
2015 Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, de Wit H, Hillard CJ, Van Cauter E. Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol. The Journal of Clinical Endocrinology and Metabolism. 100: 220-6. PMID 25368979 DOI: 10.1210/jc.2014-3455  0.68
2015 Hanlon EC, Tasali E, Leproult R, Stuhr KL, Doncheck E, De Wit H, Hillard CJ, Van Cauter E. Circadian rhythm of circulating levels of the endocannabinoid 2 arachidonoylglycerol Journal of Clinical Endocrinology and Metabolism. 100: 220-226. DOI: 10.1210/jc.20143455  1
2015 Knight JM, Szabo A, Zhao S, Lyness JM, Sahler OJZ, Liesveld JL, Sander T, Rizzo JD, Hillard CJ, Moynihan JA. Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study Neurobiology of Stress. 2: 44-50. DOI: 10.1016/j.ynstr.2015.05.001  1
2015 Hutch CR, Hillard CJ, Jia C, Hegg CC. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction Neuroscience. 300: 539-553. DOI: 10.1016/j.neuroscience.2015.05.056  1
2014 Koltyn KF, Brellenthin AG, Cook DB, Sehgal N, Hillard C. Mechanisms of exercise-induced hypoalgesia. The Journal of Pain : Official Journal of the American Pain Society. 15: 1294-1304. PMID 25261342 DOI: 10.1016/j.jpain.2014.09.006  1
2014 Fernández-Suárez D, Celorrio M, Riezu-Boj JI, Ugarte A, Pacheco R, González H, Oyarzabal J, Hillard CJ, Franco R, Aymerich MS. The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. Neurobiology of Aging. 35: 2603-16. PMID 24973119 DOI: 10.1016/j.neurobiolaging.2014.05.021  1
2014 Hillard CJ. Stress regulates endocannabinoid-CB1 receptor signaling. Seminars in Immunology. 26: 380-8. PMID 24882055 DOI: 10.1016/j.smim.2014.04.001  1
2014 Lawlor MW, Viola MG, Meng H, Edelstein RV, Liu F, Yan K, Luna EJ, Lerch-Gaggl A, Hoffmann RG, Pierson CR, Buj-Bello A, Lachey JL, Pearsall S, Yang L, Hillard CJ, et al. Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice. The American Journal of Pathology. 184: 1831-42. PMID 24726641 DOI: 10.1016/j.ajpath.2014.03.003  1
2014 Liedhegner ES, Vogt CD, Sem DS, Cunningham CW, Hillard CJ. Sterol carrier protein-2: binding protein for endocannabinoids. Molecular Neurobiology. 50: 149-58. PMID 24510313 DOI: 10.1007/s12035-014-8651-7  1
2014 Roberts CJ, Stuhr KL, Hutz MJ, Raff H, Hillard CJ. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice. Pharmacology, Biochemistry, and Behavior. 117: 17-24. PMID 24316201 DOI: 10.1016/j.pbb.2013.11.026  1
2014 Hillard CJ, Liu QS. Endocannabinoid signaling in the etiology and treatment of major depressive illness. Current Pharmaceutical Design. 20: 3795-811. PMID 24180398  1
2014 Liedhegner ES, Sasman A, Hillard CJ. Brain region-specific changes in N-acylethanolamine contents with time of day. Journal of Neurochemistry. 128: 491-506. PMID 24138639 DOI: 10.1111/jnc.12495  1
2014 Hillard CJ, Liu Qs, Liu X, Pan B, Roberts CJ, Shi L. Cannabinoids, endocannabinoids and stress Cannabinoids. 139-174. DOI: 10.1002/9781118451281.ch5  1
2013 Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology. 38: 2952-61. PMID 24035186 DOI: 10.1016/j.psyneuen.2013.08.004  1
2013 Pazos MR, Mohammed N, Lafuente H, Santos M, Martínez-Pinilla E, Moreno E, Valdizan E, Romero J, Pazos A, Franco R, Hillard CJ, Alvarez FJ, Martínez-Orgado J. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors. Neuropharmacology. 71: 282-91. PMID 23587650 DOI: 10.1016/j.neuropharm.2013.03.027  1
2013 McLaughlin RJ, Hill MN, Dang SS, Wainwright SR, Galea LA, Hillard CJ, Gorzalka BB. Upregulation of CB₁ receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. Behavioural Brain Research. 237: 333-7. PMID 23047058 DOI: 10.1016/j.bbr.2012.09.053  1
2013 Lee TT, Hill MN, Hillard CJ, Gorzalka BB. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse (New York, N.Y.). 67: 4-10. PMID 22987804 DOI: 10.1002/syn.21609  1
2013 Hill MN, Kumar SA, Filipski SB, Iverson M, Stuhr KL, Keith JM, Cravatt BF, Hillard CJ, Chattarji S, McEwen BS. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Molecular Psychiatry. 18: 1125-35. PMID 22776900 DOI: 10.1038/mp.2012.90  1
2013 Hillard CJ. Endocannabinoids, monoamines and stress Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. 173-212. DOI: 10.1007/978-1-4614-7940-6_9  1
2012 Dlugos A, Childs E, Stuhr KL, Hillard CJ, de Wit H. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2416-27. PMID 22763622 DOI: 10.1038/npp.2012.100  1
2012 Klein C, Hill MN, Chang SC, Hillard CJ, Gorzalka BB. Circulating endocannabinoid concentrations and sexual arousal in women. The Journal of Sexual Medicine. 9: 1588-601. PMID 22462722 DOI: 10.1111/j.1743-6109.2012.02708.x  1
2012 Ho WS, Hill MN, Miller GE, Gorzalka BB, Hillard CJ. Serum contents of endocannabinoids are correlated with blood pressure in depressed women. Lipids in Health and Disease. 11: 32. PMID 22373123 DOI: 10.1186/1476-511X-11-32  1
2012 McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 664-71. PMID 22325231 DOI: 10.1016/j.euroneuro.2012.01.004  1
2012 Roberts CJ, Stuhr KL, Hillard CJ. Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol. Neuroscience. 204: 74-82. PMID 22192839 DOI: 10.1016/j.neuroscience.2011.11.065  1
2012 Hillard CJ, Weinlander KM, Stuhr KL. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience. 204: 207-29. PMID 22123166 DOI: 10.1016/j.neuroscience.2011.11.020  1
2012 Bowles NP, Hill MN, Bhagat SM, Karatsoreos IN, Hillard CJ, McEwen BS. Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice. Neuroscience. 204: 83-9. PMID 21939741 DOI: 10.1016/j.neuroscience.2011.08.048  1
2012 Wang M, Hill MN, Zhang L, Gorzalka BB, Hillard CJ, Alger BE. Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation. Journal of Psychopharmacology (Oxford, England). 26: 56-70. PMID 21890595 DOI: 10.1177/0269881111409606  1
2012 Vaughn LK, Mantsch JR, Vranjkovic O, Stroh G, Lacourt M, Kreutter M, Hillard CJ. Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience. 204: 117-24. PMID 21871539 DOI: 10.1016/j.neuroscience.2011.08.021  1
2011 Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TT, Karatsoreos IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu QS, Gorzalka BB, Hillard CJ. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 10506-15. PMID 21775596 DOI: 10.1523/JNEUROSCI.0496-11.2011  1
2011 Hill MN, Hillard CJ, McEwen BS. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress. Cerebral Cortex (New York, N.Y. : 1991). 21: 2056-64. PMID 21263035 DOI: 10.1093/cercor/bhq280  1
2011 Hill JE, Makky K, Shrestha L, Hillard CJ, Gasser PJ. Natural and synthetic corticosteroids inhibit uptake 2-mediated transport in CNS neurons. Physiology & Behavior. 104: 306-11. PMID 21081135 DOI: 10.1016/j.physbeh.2010.11.012  1
2011 Merriam FV, Wang ZY, Hillard CJ, Stuhr KL, Bjorling DE. Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation. Bju International. 108: 1145-9. PMID 20804480 DOI: 10.1111/j.1464-410X.2010.09583.x  1
2010 Krebs-Kraft DL, Hill MN, Hillard CJ, McCarthy MM. Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior. Proceedings of the National Academy of Sciences of the United States of America. 107: 20535-40. PMID 21059913 DOI: 10.1073/pnas.1005003107  1
2010 Ghosh A, Chandran K, Kalivendi SV, Joseph J, Antholine WE, Hillard CJ, Kanthasamy A, Kanthasamy A, Kalyanaraman B. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radical Biology & Medicine. 49: 1674-84. PMID 20828611 DOI: 10.1016/j.freeradbiomed.2010.08.028  1
2010 Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology. 151: 4811-9. PMID 20702575 DOI: 10.1210/en.2010-0285  1
2010 Wang W, Sun D, Pan B, Roberts CJ, Sun X, Hillard CJ, Liu QS. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2249-61. PMID 20664582 DOI: 10.1038/npp.2010.99  1
2010 Ho WS, Patel S, Thompson JR, Roberts CJ, Stuhr KL, Hillard CJ. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. British Journal of Pharmacology. 160: 736-46. PMID 20590576 DOI: 10.1111/j.1476-5381.2010.00772.x  1
2010 Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? British Journal of Pharmacology. 160: 530-43. PMID 20590563 DOI: 10.1111/j.1476-5381.2010.00790.x  1
2010 Chen CY, Bonham AC, Dean C, Hopp FA, Hillard CJ, Seagard JL. Retrograde release of endocannabinoids inhibits presynaptic GABA release to second-order baroreceptive neurons in NTS. Autonomic Neuroscience : Basic & Clinical. 158: 44-50. PMID 20580326 DOI: 10.1016/j.autneu.2010.06.001  1
2010 Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, Hillard CJ, Gorzalka BB, Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proceedings of the National Academy of Sciences of the United States of America. 107: 9406-11. PMID 20439721 DOI: 10.1073/pnas.0914661107  1
2010 Hill MN, Karatsoreos IN, Hillard CJ, McEwen BS. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology. 35: 1333-8. PMID 20399021 DOI: 10.1016/j.psyneuen.2010.03.005  1
2010 Riebe CJ, Hill MN, Lee TT, Hillard CJ, Gorzalka BB. Estrogenic regulation of limbic cannabinoid receptor binding. Psychoneuroendocrinology. 35: 1265-9. PMID 20207489 DOI: 10.1016/j.psyneuen.2010.02.008  1
2010 Kalivendi SV, Yedlapudi D, Hillard CJ, Kalyanaraman B. Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease. Free Radical Biology & Medicine. 48: 377-83. PMID 19857570 DOI: 10.1016/j.freeradbiomed.2009.10.045  1
2010 Hill MN, Titterness AK, Morrish AC, Carrier EJ, Lee TT, Gil-Mohapel J, Gorzalka BB, Hillard CJ, Christie BR. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus. 20: 513-23. PMID 19489006 DOI: 10.1002/hipo.20647  1
2009 Patel S, Hillard CJ. Role of endocannabinoid signaling in anxiety and depression. Current Topics in Behavioral Neurosciences. 1: 347-71. PMID 21104391 DOI: 10.1007/978-3-540-88955-7_14  1
2009 Zhang Y, Sonnenberg GE, Baye TM, Littrell J, Gunnell J, DeLaForest A, MacKinney E, Hillard CJ, Kissebah AH, Olivier M, Wilke RA. Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent. Pharmacogenomics. 10: 1929-39. PMID 19958092 DOI: 10.2217/pgs.09.122  1
2009 Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences. 30: 484-93. PMID 19732971 DOI: 10.1016/j.tips.2009.06.006  1
2009 Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2733-45. PMID 19710634 DOI: 10.1038/npp.2009.114  1
2009 Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF, Liu QS. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. The Journal of Pharmacology and Experimental Therapeutics. 331: 591-7. PMID 19666749 DOI: 10.1124/jpet.109.158162  1
2009 Brozoski DT, Dean C, Hopp FA, Hillard CJ, Seagard JL. Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats. Autonomic Neuroscience : Basic & Clinical. 150: 82-93. PMID 19464961 DOI: 10.1016/j.autneu.2009.05.243  1
2009 Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology. 34: 1257-62. PMID 19394765 DOI: 10.1016/j.psyneuen.2009.03.013  1
2009 Hill MN, Ho WSV, Hillard CJ, Gorzalka BB. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents (Journal of Neural Transmission (2008) 115, (1673-1679) DOI: 10.1007/s00702-008-0131-7) Journal of Neural Transmission. 116: 141. DOI: 10.1007/s00702-008-0172-y  1
2008 Pan B, Hillard CJ, Liu QS. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14018-30. PMID 19109485 DOI: 10.1523/JNEUROSCI.4035-08.2008  1
2008 Baye TM, Zhang Y, Smith E, Hillard CJ, Gunnell J, Myklebust J, James R, Kissebah AH, Olivier M, Wilke RA. Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index. Pharmacogenomics. 9: 1647-56. PMID 19018721 DOI: 10.2217/14622416.9.11.1647  1
2008 Hill MN, Ho WS, Hillard CJ, Gorzalka BB. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1673-9. PMID 18974922 DOI: 10.1007/s00702-008-0131-7  1
2008 Hillard CJ. Role of cannabinoids and endocannabinoids in cerebral ischemia. Current Pharmaceutical Design. 14: 2347-61. PMID 18781985 DOI: 10.2174/138161208785740054  1
2008 Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, Gorzalka BB. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. Journal of Neurochemistry. 106: 2322-36. PMID 18643796 DOI: 10.1111/j.1471-4159.2008.05567.x  1
2008 Liou GI, Auchampach JA, Hillard CJ, Zhu G, Yousufzai B, Mian S, Khan S, Khalifa Y. Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Investigative Ophthalmology & Visual Science. 49: 5526-31. PMID 18641283 DOI: 10.1167/iovs.08-2196  1
2008 Patel S, Hillard CJ. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. The European Journal of Neuroscience. 27: 2821-9. PMID 18588527 DOI: 10.1111/j.1460-9568.2008.06266.x  1
2008 Gorzalka BB, Hill MN, Hillard CJ. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neuroscience and Biobehavioral Reviews. 32: 1152-60. PMID 18433869 DOI: 10.1016/j.neubiorev.2008.03.004  1
2008 Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry. 41: 48-53. PMID 18311684 DOI: 10.1055/s-2007-993211  1
2008 Pan B, Hillard CJ, Liu QS. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 1385-97. PMID 18256258 DOI: 10.1523/JNEUROSCI.4033-07.2008  1
2008 Yang W, Tuniki VR, Anjaiah S, Falck JR, Hillard CJ, Campbell WB. Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125i-14,15-epoxyeicosa-8(Z)-enoic acid. The Journal of Pharmacology and Experimental Therapeutics. 324: 1019-27. PMID 18171909 DOI: 10.1124/jpet.107.129577  1
2008 Núñez E, Benito C, Tolón RM, Hillard CJ, Griffin WS, Romero J. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome. Neuroscience. 151: 104-10. PMID 18068305 DOI: 10.1016/j.neuroscience.2007.10.029  1
2008 Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB, Hillard CJ. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus. 18: 221-6. PMID 18058925 DOI: 10.1002/hipo.20386  1
2008 Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology. 54: 108-16. PMID 17675104 DOI: 10.1016/j.neuropharm.2007.06.012  1
2007 Hillard CJ, Shi L, Tuniki VR, Falck JR, Campbell WB. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. Journal of Molecular Neuroscience : Mn. 33: 18-24. PMID 17901541 DOI: 10.1007/s12031-007-0045-0  1
2007 Hillard CJ, Ho WS, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. British Journal of Pharmacology. 152: 691-8. PMID 17891162 DOI: 10.1038/sj.bjp.0707468  1
2007 Hill MN, Barr AM, Ho WS, Carrier EJ, Gorzalka BB, Hillard CJ. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. Journal of Neurochemistry. 103: 47-56. PMID 17561935 DOI: 10.1111/j.1471-4159.2007.04688.x  1
2007 Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nature Medicine. 13: 492-7. PMID 17401376 DOI: 10.1038/nm1561  1
2007 Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2396-402. PMID 17329437 DOI: 10.1523/JNEUROSCI.4814-06.2007  1
2007 Rademacher DJ, Hillard CJ. Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 633-41. PMID 17258369 DOI: 10.1016/j.pnpbp.2006.12.013  1
2006 Hill MN, Ho WS, Sinopoli KJ, Viau V, Hillard CJ, Gorzalka BB. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2591-9. PMID 16710317 DOI: 10.1038/sj.npp.1301092  1
2006 Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences of the United States of America. 103: 7895-900. PMID 16672367 DOI: 10.1073/pnas.0511232103  1
2006 Patel S, Hillard CJ. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. The Journal of Pharmacology and Experimental Therapeutics. 318: 304-11. PMID 16569753 DOI: 10.1124/jpet.106.101287  1
2006 Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood. 107: 3173-80. PMID 16380449 DOI: 10.1182/blood-2005-10-4111  1
2006 Tang X, Holmes BB, Nithipatikom K, Hillard CJ, Kuhn H, Campbell WB. Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 78-84. PMID 16239596 DOI: 10.1161/01.ATV.0000191640.73313.ad  1
2005 Ho WS, Hillard CJ. Modulators of endocannabinoid enzymic hydrolysis and membrane transport. Handbook of Experimental Pharmacology. 187-207. PMID 16596775 DOI: 10.1007/3-540-26573-2-6  1
2005 Carrier EJ, Patel S, Hillard CJ. Endocannabinoids in neuroimmunology and stress. Current Drug Targets. Cns and Neurological Disorders. 4: 657-65. PMID 16375683  1
2005 Hill MN, Ho WS, Meier SE, Gorzalka BB, Hillard CJ. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. European Journal of Pharmacology. 528: 99-102. PMID 16324692 DOI: 10.1016/j.ejphar.2005.10.058  1
2005 Shang T, Kotamraju S, Zhao H, Kalivendi SV, Hillard CJ, Kalyanaraman B. Sepiapterin attenuates 1-methyl-4-phenylpyridinium-induced apoptosis in neuroblastoma cells transfected with neuronal NOS: role of tetrahydrobiopterin, nitric oxide, and proteasome activation. Free Radical Biology & Medicine. 39: 1059-74. PMID 16198233 DOI: 10.1016/j.freeradbiomed.2005.05.022  1
2005 Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. Journal of Neurochemistry. 95: 437-45. PMID 16086683 DOI: 10.1111/j.1471-4159.2005.03380.x  1
2005 Shang T, Joseph J, Hillard CJ, Kalyanaraman B. Death-associated protein kinase as a sensor of mitochondrial membrane potential: role of lysosome in mitochondrial toxin-induced cell death. The Journal of Biological Chemistry. 280: 34644-53. PMID 16085644 DOI: 10.1074/jbc.M506466200  1
2005 Hillard CJ. Lipids and drugs of abuse. Life Sciences. 77: 1531-42. PMID 15946699 DOI: 10.1016/j.lfs.2005.05.004  1
2005 Hillard CJ, Jarrahian A. Accumulation of anandamide: evidence for cellular diversity. Neuropharmacology. 48: 1072-8. PMID 15910883 DOI: 10.1016/j.neuropharm.2004.12.012  1
2005 Seagard JL, Hopp FA, Hillard CJ, Dean C. Effects of endocannabinoids on discharge of baroreceptive NTS neurons. Neuroscience Letters. 381: 334-9. PMID 15896495 DOI: 10.1016/j.neulet.2005.02.044  1
2005 Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. The European Journal of Neuroscience. 21: 1057-69. PMID 15787710 DOI: 10.1111/j.1460-9568.2005.03916.x  1
2005 Benito C, Kim WK, Kim WK, Chavarría I, Hillard CJ, Mackie K, Tolón RM, Williams K, Williams K, Romero J. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2530-6. PMID 15758162 DOI: 10.1523/JNEUROSCI.3923-04.2005  1
2005 Rademacher DJ, Patel S, Ho WS, Savoie AM, Rusch NJ, Gauthier KM, Hillard CJ. U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance. American Journal of Physiology. Heart and Circulatory Physiology. 288: H2694-701. PMID 15695564 DOI: 10.1152/ajpheart.00978.2004  1
2005 Sato H, Feix JB, Hillard CJ, Frank DW. Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU. Journal of Bacteriology. 187: 1192-5. PMID 15659695 DOI: 10.1128/JB.187.3.1192-1195.2005  1
2005 Patel S, Carrier EJ, Ho WS, Rademacher DJ, Cunningham S, Reddy DS, Falck JR, Cravatt BF, Hillard CJ. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. Journal of Lipid Research. 46: 342-9. PMID 15576840 DOI: 10.1194/jlr.M400377-JLR200  1
2005 Gauthier KM, Baewer DV, Hittner S, Hillard CJ, Nithipatikom K, Reddy DS, Falck JR, Campbell WB. Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. American Journal of Physiology. Heart and Circulatory Physiology. 288: H1344-51. PMID 15528233 DOI: 10.1152/ajpheart.00537.2004  0.44
2005 Rademacher DJ, Weber DN, Hillard CJ. Waterborne lead exposure affects brain endocannabinoid content in male but not female fathead minnows (Pimephales promelas). Neurotoxicology. 26: 9-15. PMID 15527869 DOI: 10.1016/j.neuro.2004.08.001  1
2005 Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 508-15. PMID 15525997 DOI: 10.1038/sj.npp.1300601  1
2005 Patel S, Cravatt BF, Hillard CJ. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 497-507. PMID 15280883 DOI: 10.1038/sj.npp.1300535  1
2004 Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB. 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Research. 64: 8826-30. PMID 15604240 DOI: 10.1158/0008-5472.CAN-04-3136  1
2004 Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience. 129: 743-50. PMID 15541895 DOI: 10.1016/j.neuroscience.2004.08.044  1
2004 Lu H, Patel S, Luo F, Li SJ, Hillard CJ, Ward BD, Hyde JS. Spatial correlations of laminar BOLD and CBV responses to rat whisker stimulation with neuronal activity localized by Fos expression. Magnetic Resonance in Medicine. 52: 1060-8. PMID 15508149 DOI: 10.1002/mrm.20265  1
2004 Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 145: 5431-8. PMID 15331569 DOI: 10.1210/en.2004-0638  1
2004 Hirasawa M, Schwab Y, Natah S, Hillard CJ, Mackie K, Sharkey KA, Pittman QJ. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. The Journal of Physiology. 559: 611-24. PMID 15254151 DOI: 10.1113/jphysiol.2004.066159  1
2004 Nithipatikom K, Holmes BB, McCoy MJ, Hillard CJ, Campbell WB. Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells. American Journal of Physiology. Endocrinology and Metabolism. 287: E820-7. PMID 15198935 DOI: 10.1152/ajpendo.00183.2004  1
2004 Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Molecular Pharmacology. 65: 999-1007. PMID 15044630 DOI: 10.1124/mol.65.4.999  1
2004 Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgado MA, Barkmeier A, Klick DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Production of hydroxyeicosatetraenoic acids and prostaglandins by a novel rat microglial cell line. Journal of Neuroimmunology. 149: 130-41. PMID 15020073 DOI: 10.1016/j.jneuroim.2003.12.022  1
2004 Shang T, Kotamraju S, Kalivendi SV, Hillard CJ, Kalyanaraman B. 1-Methyl-4-phenylpyridinium-induced apoptosis in cerebellar granule neurons is mediated by transferrin receptor iron-dependent depletion of tetrahydrobiopterin and neuronal nitric-oxide synthase-derived superoxide. The Journal of Biological Chemistry. 279: 19099-112. PMID 14752097 DOI: 10.1074/jbc.M400101200  1
2004 Kalivendi SV, Cunningham S, Kotamraju S, Joseph J, Hillard CJ, Kalyanaraman B. Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide. The Journal of Biological Chemistry. 279: 15240-7. PMID 14742448 DOI: 10.1074/jbc.M312497200  1
2004 Ruiz-Llorente L, Ortega-Gutiérrez S, Viso A, Sánchez MG, Sánchez AM, Fernández C, Ramos JA, Hillard C, Lasunción MA, López-Rodríguez ML, Díaz-Laviada I. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study. British Journal of Pharmacology. 141: 457-67. PMID 14718261 DOI: 10.1038/sj.bjp.0705628  1
2004 Seagard JL, Dean C, Patel S, Rademacher DJ, Hopp FA, Schmeling WT, Hillard CJ. Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. American Journal of Physiology. Heart and Circulatory Physiology. 286: H992-1000. PMID 14615281 DOI: 10.1152/ajpheart.00870.2003  1
2003 Benito C, Núñez E, Tolón RM, Carrier EJ, Rábano A, Hillard CJ, Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11136-41. PMID 14657172  1
2003 Hillard CJ, Jarrahian A. Cellular accumulation of anandamide: consensus and controversy. British Journal of Pharmacology. 140: 802-8. PMID 12970089 DOI: 10.1038/sj.bjp.0705468  1
2003 Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. British Journal of Pharmacology. 139: 1005-13. PMID 12839875 DOI: 10.1038/sj.bjp.0705334  1
2003 Patel S, Rademacher DJ, Hillard CJ. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. The Journal of Pharmacology and Experimental Therapeutics. 306: 880-8. PMID 12808005 DOI: 10.1124/jpet.103.054270  1
2003 Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama K, Finck-Barbançon V, Buchaklian A, Lei M, Long RM, Wiener-Kronish J, Sawa T. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. The Embo Journal. 22: 2959-69. PMID 12805211 DOI: 10.1093/emboj/cdg290  1
2003 El Fangour S, Balas L, Rossi JC, Fedenyuk A, Gretskaya N, Bobrov M, Bezuglov V, Hillard CJ, Durand T. Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues. Bioorganic & Medicinal Chemistry Letters. 13: 1977-80. PMID 12781177 DOI: 10.1016/S0960-894X(03)00348-2  1
2003 Shang T, Uihlein AV, Van Asten J, Kalyanaraman B, Hillard CJ. 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. Journal of Neurochemistry. 85: 358-67. PMID 12675912  1
2003 Patel S, Hillard CJ. Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Research. 963: 15-25. PMID 12560108 DOI: 10.1016/S0006-8993(02)03797-6  1
2003 Kalivendi SV, Kotamraju S, Cunningham S, Shang T, Hillard CJ, Kalyanaraman B. 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. The Biochemical Journal. 371: 151-64. PMID 12523938 DOI: 10.1042/BJ20021525  1
2003 Rademacher DJ, Patel S, Hopp FA, Dean C, Hillard CJ, Seagard JL. Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. American Journal of Physiology. Heart and Circulatory Physiology. 284: H1570-6. PMID 12521935 DOI: 10.1152/ajpheart.00772.2002  1
2002 Patel S, Gerrits R, Muthian S, Greene AS, Hillard CJ. The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat. Neuroscience Letters. 335: 95-8. PMID 12459507 DOI: 10.1016/S0304-3940(02)01170-9  1
2002 Inui A, Van Sickle M, Davison J, Sharkey K, Mackie K, Hillard C. Emesis, appetite, and endocannabinoids [5] (multiple letters) Gastroenterology. 123: 655-656. PMID 12145832  1
2002 Romero J, Hillard CJ, Calero M, Rábano A. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Research. Molecular Brain Research. 100: 85-93. PMID 12008024 DOI: 10.1016/S0169-328X(02)00167-5  1
2001 Nogueron MI, Porgilsson B, Schneider WE, Stucky CL, Hillard CJ. Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. Journal of Neurochemistry. 79: 371-81. PMID 11677265 DOI: 10.1046/j.1471-4159.2001.00567.x  1
2001 Van Sickle MD, Oland LD, Ho W, Hillard CJ, Mackie K, Davison JS, Sharkey KA. Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology. 121: 767-74. PMID 11606489  1
2001 Patel S, Hillard CJ. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. The Journal of Pharmacology and Experimental Therapeutics. 297: 629-37. PMID 11303052  1
2001 Bisogno T, MacCarrone M, De Petrocellis L, Jarrahian A, Finazzi-Agrò A, Hillard C, Di Marzo V. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. European Journal of Biochemistry / Febs. 268: 1982-9. PMID 11277920 DOI: 10.1046/j.1432-1327.2001.02072.x  1
2001 Pratt PF, Li P, Hillard CJ, Kurian J, Campbell WB. Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. American Journal of Physiology. Heart and Circulatory Physiology. 280: H1113-21. PMID 11179054 DOI: 10.1152/ajpheart.2001.280.3.H1113  1
2001 Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. The Journal of Biological Chemistry. 276: 6967-73. PMID 11118429 DOI: 10.1074/jbc.M003161200  1
2000 Hillard CJ, Jarrahian A. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chemistry and Physics of Lipids. 108: 123-34. PMID 11106786 DOI: 10.1016/S0009-3084(00)00191-2  1
2000 Tyler K, Hillard CJ, Greenwood-Van Meerveld B. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats. European Journal of Pharmacology. 409: 207-11. PMID 11104836 DOI: 10.1016/S0014-2999(00)00843-8  1
2000 Hillard CJ. Endocannabinoids and vascular function. The Journal of Pharmacology and Experimental Therapeutics. 294: 27-32. PMID 10871291  1
2000 Jarrahian A, Manna S, Edgemond WS, Campbell WB, Hillard CJ. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. Journal of Neurochemistry. 74: 2597-606. PMID 10820223 DOI: 10.1046/j.1471-4159.2000.0742597.x  1
2000 Hillard CJ. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins & Other Lipid Mediators. 61: 3-18. PMID 10785538 DOI: 10.1016/S0090-6980(00)00051-4  1
2000 Muthian S, Nithipatikom K, Campbell WB, Hillard CJ. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. The Journal of Pharmacology and Experimental Therapeutics. 293: 289-95. PMID 10734181  1
1999 Hillard CJ, Muthian S, Kearn CS. Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. Febs Letters. 459: 277-81. PMID 10518035 DOI: 10.1016/S0014-5793(99)01253-3  1
1999 Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. The American Journal of Physiology. 276: H2085-93. PMID 10362691  1
1999 Kearn CS, Greenberg MJ, DiCamelli R, Kurzawa K, Hillard CJ. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange. Journal of Neurochemistry. 72: 2379-87. PMID 10349847 DOI: 10.1046/j.1471-4159.1999.0722379.x  1
1999 Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). The Journal of Pharmacology and Experimental Therapeutics. 289: 1427-33. PMID 10336536  1
1998 Pratt PF, Hillard CJ, Edgemond WS, Campbell WB. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. American Journal of Physiology. Heart and Circulatory Physiology. 274: H375-H381. PMID 29591500 DOI: 10.1152/ajpheart.1998.274.1.H375  0.4
1998 Tsou K, Nogueron MI, Muthian S, Sañudo-Pena MC, Hillard CJ, Deutsch DG, Walker JM. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neuroscience Letters. 254: 137-40. PMID 10214976 DOI: 10.1016/S0304-3940(98)00700-9  1
1998 Edgemond WS, Hillard CJ, Falck JR, Kearn CS, Campbell WB. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Molecular Pharmacology. 54: 180-8. PMID 9658204  1
1998 Edgemond WS, Greenberg MJ, McGinley PJ, Muthian S, Campbell WB, Hillard CJ. Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. The Journal of Pharmacology and Experimental Therapeutics. 286: 184-90. PMID 9655859  1
1998 Pratt PF, Hillard CJ, Edgemond WS, Campbell WB. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. The American Journal of Physiology. 274: H375-81. PMID 9458889  1
1997 Hillard CJ, Campbell WB. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. Journal of Lipid Research. 38: 2383-98. PMID 9458263  1
1997 Jarrahian A, Hillard CJ. Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 57: 551-4. PMID 9431821  1
1997 Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry. 69: 631-8. PMID 9231721  1
1997 Smith JJ, Lee JG, Hudetz AG, Hillard CJ, Bosnjak ZJ, Kampine JP. The role of nitric oxide in the cerebrovascular response to hypercapnia. Anesthesia and Analgesia. 84: 363-9. PMID 9024030 DOI: 10.1097/00000539-199702000-00023  1
1996 Hillard CJ. Nicotinic cholinergic receptors (nAChR) are present on cerebellar granule cells and mediate calcium influx Faseb Journal. 10: A141.  1
1996 Gebremedhin D, Campbell WB, Hillard CJ, Hantel DR. Inhibitory effects of anandamide on ca2 + currents in cat cerebral arterial smooth muscle cells Faseb Journal. 10: A302.  1
1995 Jouët P, Sarna SK, Singaram C, Ryan RP, Hillard CJ, Telford GL, Fink J, Henderson JD. Immunocytes and abnormal gastrointestinal motor activity during ileitis in dogs. The American Journal of Physiology. 269: G913-24. PMID 8572223  1
1995 Lee JG, Smith JJ, Hudetz AG, Hillard CJ, Bosnjak ZJ, Kampine JP. Laser-Doppler measurement of the effects of halothane and isoflurane on the cerebrovascular CO2 response in the rat. Anesthesia and Analgesia. 80: 696-702. PMID 7893020 DOI: 10.1097/00000539-199504000-00008  1
1995 Hillard CJ, Edgemond WS, Campbell WB. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. Journal of Neurochemistry. 64: 677-83. PMID 7830060  1
1995 Edgemond WS, Campbell WB, Hillard CJ. The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 52: 83-6. PMID 7784462 DOI: 10.1016/0952-3278(95)90002-0  1
1995 Hillard CJ, Wilkison DM, Edgemond WS, Campbell WB. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochimica Et Biophysica Acta. 1257: 249-56. PMID 7647100 DOI: 10.1016/0005-2760(95)00087-S  1
1994 Hillard CJ, Auchampach JA. In vitro activation of brain protein kinase C by the cannabinoids. Biochimica Et Biophysica Acta. 1220: 163-70. PMID 8312360 DOI: 10.1016/0167-4889(94)90131-7  1
1994 Wilke RA, Hillard CJ. Decreased adrenal medullary catecholamine release in spontaneously diabetic BB-Wistar rats. Role of hypoglycemia. Diabetes. 43: 724-9. PMID 8168651  1
1994 Lee JG, Hudetz AG, Smith JJ, Hillard CJ, Bosnjak ZJ, Kampine JP. The effects of halothane and isoflurane on cerebrocortical microcirculation and autoregulation as assessed by laser-Doppler flowmetry. Anesthesia and Analgesia. 79: 58-65. PMID 8010455  1
1993 Wilke RA, Riley DA, Lelkes PI, Hillard CJ. Decreased catecholamine secretion from the adrenal medullae of chronically diabetic BB-Wistar rats. Diabetes. 42: 862-8. PMID 8495810  1
1993 Hillard CJ, Pounds JJ. Effects of chronic nicotine treatment on the accumulation of [3H]tetraphenylphosphonium by cerebral cortical synaptosomes. Journal of Neurochemistry. 60: 687-95. PMID 8419544  1
1992 Hillard CJ. Nicotine-induced depolarization of cerebral cortical synaptosomes is dependent upon sodium. Neuropharmacology. 31: 909-14. PMID 1436397 DOI: 10.1016/0028-3908(92)90129-D  1
1992 Eskinder H, Hillard CJ, Flynn N, Bosnjak ZJ, Kampine JP. Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries. Anesthesiology. 77: 482-7. PMID 1355637 DOI: 10.1097/00000542-199209000-00013  1
1991 Hillard CJ, Pounds JJ. [3H]tetraphenylphosphonium accumulation in cerebral cortical synaptosomes as a measure of nicotine-induced changes in membrane potential. The Journal of Pharmacology and Experimental Therapeutics. 259: 1118-23. PMID 1762066  1
1989 Eskinder H, Hillard CJ, Wilke RA, Gross GJ. Effect of KT-362, a putative intracellular calcium antagonist, on norepinephrine-induced contractions and inositol monophosphate accumulation in canine femoral artery. Journal of Cardiovascular Pharmacology. 13: 502-7. PMID 2471898  0.36
1988 Eskinder H, Hillard CJ, Olinger GN, Christensen CW, Baker JE, Warltier DC, Gross GJ. Alpha adrenoceptor subtypes and receptor reserve in human versus canine saphenous vein: sensitivity to blockade by nitroglycerin. The Journal of Pharmacology and Experimental Therapeutics. 247: 941-8. PMID 2905005  0.36
1984 Hillard CJ, Farber NE, Hagen TC, Bloom AS. The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacology, Biochemistry, and Behavior. 20: 547-50. PMID 6328543 DOI: 10.1016/0091-3057(84)90303-4  1
Show low-probability matches.